ASRS
ALNY icon

Arizona State Retirement System’s Alnylam Pharmaceuticals ALNY Stock Holding History

Arizona State Retirement System’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
38,025
+2,126
+6% +$641K 0.06% 266
2026
Q1 		$11.9M Sell
35,899
-491
-1% -$167K 0.07% 234
2025
Q4 		$14.5M Sell
36,390
-2,122
-6% -$939K 0.08% 204
2025
Q3 		$17.6M Buy
38,512
+584
+2% +$238K 0.09% 178
2025
Q2 		$12.4M Buy
37,928
+680
+2% +$188K 0.07% 240
2025
Q1 		$10.1M Buy
37,248
+44
+0.1% +$11.3K 0.06% 258
2024
Q4 		$8.75M Buy
37,204
+964
+3% +$254K 0.05% 300
2024
Q3 		$9.97M Buy
36,240
+1,504
+4% +$392K 0.06% 275
2024
Q2 		$8.44M Buy
34,736
+219
+0.6% +$34.6K 0.06% 286
2024
Q1 		$5.16M Buy
34,517
+161
+0.5% +$26.9K 0.04% 398
2023
Q4 		$6.58M Buy
34,356
+383
+1% +$65.2K 0.05% 326
2023
Q3 		$6.02M Buy
33,973
+153
+0.5% +$29.2K 0.05% 323
2023
Q2 		$6.42M Sell
33,820
-1,947
-5% -$386K 0.05% 327
2023
Q1 		$7.16M Buy
35,767
+1,793
+5% +$377K 0.06% 300
2022
Q4 		$8.07M Buy
33,974
+803
+2% +$171K 0.08% 255
2022
Q3 		$6.64M Sell
33,171
-379
-1% -$72.3K 0.07% 274
2022
Q2 		$4.89M Buy
33,550
+258
+0.8% +$36.6K 0.05% 360
2022
Q1 		$5.44M Buy
33,292
+933
+3% +$142K 0.04% 378
2021
Q4 		$5.49M Sell
32,359
-629
-2% -$117K 0.04% 394
2021
Q3 		$6.23M Sell
32,988
-82
-0.2% -$15.4K 0.05% 341
2021
Q2 		$5.61M Sell
33,070
-428
-1% -$62.7K 0.05% 382
2021
Q1 		$4.73M Buy
33,498
+243
+0.7% +$36.6K 0.04% 423
2020
Q4 		$4.32M Sell
33,255
-1,683
-5% -$225K 0.04% 414
2020
Q3 		$5.09M Buy
34,938
+8,713
+33% +$1.24M 0.05% 328
2020
Q2 		$3.88M Buy
26,225
+568
+2% +$76.6K 0.05% 316
2020
Q1 		$2.79M Buy
+25,657
New +$2.96M 0.05% 393

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arizona State Retirement System's ALNY Position: Q2 2026 in Review

Arizona State Retirement System increased its Alnylam Pharmaceuticals (ALNY) stake by 5.9% in Q2 2026, buying an estimated $641K and bringing the position to 38,025 shares worth $11.4M. The position accounts for 0.06% of the portfolio, ranked #266.

Arizona State Retirement System first reported a position in ALNY in Q1 2020 and has held it in 26 quarters since. The position peaked at $17.6M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Arizona State Retirement System held 38,025 shares of Alnylam Pharmaceuticals worth $11.4M as of Q2 2026.
  • Arizona State Retirement System bought 2,126 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $641K.
  • Alnylam Pharmaceuticals made up 0.06% of Arizona State Retirement System's portfolio in Q2 2026, its #266 holding.
  • Arizona State Retirement System first reported a position in Alnylam Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Arizona State Retirement System's Alnylam Pharmaceuticals position peaked at $17.6M in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.